Abstract
Background
Minimally invasive parathyroidectomy (MIP) has become a well-accepted treatment for selected patients with primary hyperparathyroidism (PHPT). However, few studies have evaluated long-term outcomes for this operative approach. We therefore chose to examine both the long-term symptom resolution and biochemical cure following MIP for PHPT.
Methods
A total of 460 PHPT patients who underwent a MIP between 2004 and 2009 were successfully mailed a questionnaire that assessed preoperative and postoperative Parathyroidectomy Assessment of Symptoms (PAS) scores, most recent calcium and parathyroid hormone (PTH) levels, and information about any reoperation for PHPT. Long-term evaluation of symptomatic and biochemical cure was performed.
Results
A total of 200 patients (43.5%) responded to our correspondence. The mean age of the patients was 58.7 ± 11.9 years, 74.5% were female, and 78.5% were Caucasian. The mean follow-up was 37 ± 19 months. The mean PAS scores fell by 117 ± 14 at long-term follow-up after MIP (P < 0.0001). All 13 symptoms comprising the PAS score diminished, of which ten did so significantly (P < 0.01). There was a significant drop in the mean serum calcium (preop. 11.1 mg/dl, postop. 9.6 mg/dl; P < 0.0001) and PTH (preop. 130.9 pg/ml, postop. 45.7 pg/ml; P < 0.0001) at long-term follow-up. Five patients (2.5%) developed recurrent disease (calcium > 10.5 mg/dl), and one (0.5%) underwent a reoperation for persistent disease and was subsequently cured.
Conclusions
This study demonstrates that MIP has long-term benefits in terms of excellent symptom resolution and a high biochemical cure rate (97%) in selected patients who have PHPT, preoperative localization with sestamibi scans, and assessment of intraoperative PTH level.
Similar content being viewed by others
References
Eigelberger MS, Cheah WK, Ituarte PH et al (2004) The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: Are they too limited? Ann Surg 239:528–535
Sitges-Serra A, Bergenfelz A (2007) Clinical update: sporadic primary hyperparathyroidism. Lancet 370:468–470
Pelizzo MR, Pagetta C, Piotto A et al (2008) Surgical treatment of primary hyperparathyroidism: from bilateral neck exploration to minimally invasive surgery. Minerva Endocr 33:85–93
Bergenfelz A, Kanngiesser V, Zielke A et al (2005) Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br J Surg 92:190–197
Lavely WC, Goetze S, Friedman KP et al (2007) Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 48:1084–1089
Mihai R, Gleeson F, Buley ID et al (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30:697–704. doi:10.1007/s00268-005-0338-9
Heller KS, Blumberg SN (2009) Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy. Arch Otolaryngol Head Neck Surg 135:1103–1107
Chen H, Pruhs Z, Starling JR et al (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583–587 discussion 587–590
Bergenfelz A, Lindblom P, Tibblin S et al (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551
Westerdahl J, Bergenfelz A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246:976–980 discussion 980–971
Goldstein RE, Blevins L, Delbeke D et al (2000) Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 231:732–742
Tang T, Dolan S, Robinson B et al (2007) Does the surgical approach affect quality of life outcomes? A comparison of minimally invasive parathyroidectomy with open parathyroidectomy. Int J Surg 5:17–22
Aspinall SR, Boase S, Malycha P (2010) Long-term symptom relief from primary hyperparathyroidism following minimally invasive parathyroidectomy. World J Surg 34:2223–2227. doi:10.1007/s00268-010-0687-x
Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10 year prospective surgical outcome study. Surgery 146:1006–1013
Sidhu S, Neill AK, Russell CFJ (2003) Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma. World J Surg 27:339–342. doi:10.1007/s00268-002-6695-8
Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518. doi:10.1007/s002689900428 discussion 518–519
Greutelaers B, Kullen K, Kollias J et al (2004) Pasieka illness questionnaire: its value in primary hyperparathyroidism. ANZ J Surg 74:112–115
Pasieka JL, Parsons LL, Demeure MJ et al (2002) Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26:942–949. doi:10.1007/s00268-002-6623-y
Mihai R, Sadler GP (2008) Pasieka’s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg 32:807–814. doi:10.1007/s00268-008-9509-9
Irvin GL 3rd, Molinari AS, Figueroa C et al (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229:874–878 discussion 878–879
Irvin GL 3rd, Deriso GT 3rd (1994) A new, practical intraoperative parathyroid hormone assay. Am J Surg 168:466–468
Irvin GL 3rd, Dembrow VD, Prudhomme DL (1993) Clinical usefulness of an intraoperative “quick parathyroid hormone” assay. Surgery 114:1019–1022 discussion 1022–1013
Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692. doi:10.1007/BF01665301
Kaplan EL, Yashiro T, Salti G (1992) Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg 215:300–317
Tibblin S, Bondeson AG, Ljungberg O (1982) Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 195:245–252
Russell CF, Laird JD, Ferguson WR (1990) Scan-directed unilateral cervical exploration for parathyroid adenoma: A legitimate approach? World J Surg 14:406–409. doi:10.1007/BF01658540
Dackiw AP, Sussman JJ, Fritsche HA Jr et al (2000) Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 135:550–555 discussion 555–557
Udelsman R, Donovan PI, Sokoll LJ (2000) One hundred consecutive minimally invasive parathyroid explorations. Ann Surg 232:331–339
Irvin GL 3rd, Prudhomme DL, Deriso GT et al (1994) A new approach to parathyroidectomy. Ann Surg 219:574–579 discussion 579–581
Shabtai M, Ben-Haim M, Muntz Y et al (2003) 140 consecutive cases of minimally invasive, radio-guided parathyroidectomy: lessons learned and long-term results. Surg Endosc 17:688–691
Conflict of interest
The authors have no conflicts of interest, commercial associations, or intent of financial gain regarding the presented study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Venkat, R., Kouniavsky, G., Tufano, R.P. et al. Long-Term Outcome in Patients with Primary Hyperparathyroidism who Underwent Minimally Invasive Parathyroidectomy. World J Surg 36, 55–60 (2012). https://doi.org/10.1007/s00268-011-1344-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-011-1344-8